Guidelines for botulinum neurotoxin injections in piriformis syndrome
Background The piriformis muscle is normally involved in piriformis syndrome and can be treated with botulinum neurotoxin using several different injection methods. However, definitive injection guidelines for the muscle have not been reported previously. Aims This study aimed to determine the ideal...
Gespeichert in:
Veröffentlicht in: | Clinical anatomy (New York, N.Y.) N.Y.), 2021-10, Vol.34 (7), p.1028-1034 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1034 |
---|---|
container_issue | 7 |
container_start_page | 1028 |
container_title | Clinical anatomy (New York, N.Y.) |
container_volume | 34 |
creator | Yi, Kyu‐Ho Lee, Kyu‐Lim Lee, Ji‐Hyun Hu, Hye‐Won Lee, Kangwoo Seo, Kyle K. Kim, Hee‐Jin |
description | Background
The piriformis muscle is normally involved in piriformis syndrome and can be treated with botulinum neurotoxin using several different injection methods. However, definitive injection guidelines for the muscle have not been reported previously.
Aims
This study aimed to determine the ideal area for injections based on the intramuscular nerve distribution as obtained using a modified Sihler's staining technique.
Materials and Methods
A modified Sihler's method was applied to the piriformis muscle in 15 specimens. The intramuscular arborization areas were identified based on two anatomical landmarks: (a) the lateral border of the sacrum bone and (b) the greater trochanter.
Results
The nerve entry point for both piriformis muscles was found in the area between the lateral border of the sacrum and one‐fifth of the distance toward the greater trochanter. The intramuscular nerve distribution for the piriformis muscle had the largest arborization patterns between one‐fifth and two‐fifths of the distance from the sacrum to the greater trochanter. The piriformis muscle was tendinous from two‐fifths of the distance to the greater trochanter.
Discussion
This study has yielded suggested optimal injection locations for the piriformis muscle relative to external anatomical landmarks.
Conclusion
Clinicians can use these guidelines to ensure the effectiveness of not only botulinum neurotoxin injections but also other agents such as steroids, anesthetics, and normal saline. These guidelines will also help to avoid adverse outcomes of injection treatments. |
doi_str_mv | 10.1002/ca.23711 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2570960026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2570960026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3491-bdaf49387d220913f1ba549de52514efb7a9fbadebf8fadb40e2f1d24f502f753</originalsourceid><addsrcrecordid>eNp1kE1LAzEQQIMotlbBXyALXrxszedmcyylVqHgRc8h2SSQ0t3UZBftvzd1qzdPMwOPN_AAuEVwjiDEj42aY8IROgNTBEVdYsLIOZjCWvCS1LCagKuUthAiRHl9CSaEEMorXk_Baj14Y3e-s6lwIRY69EO-hrbo7BBDH758V_hua5vehy7ltdj76DPa-lSkQ2diaO01uHBql-zNac7A-9Pqbflcbl7XL8vFpmwIFajURjkqSM0NxlAg4pBWjApjGWaIWqe5Ek4rY7WrnTKaQosdMpg6BrHjjMzA_ejdx_Ax2NTLbRhil19KzDgUVY5RZephpJoYUorWyX30rYoHiaA89pKNkj-9Mnp3Eg66teYP_A2UgXIEPv3OHv4VyeViFH4DwrB0Qg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2570960026</pqid></control><display><type>article</type><title>Guidelines for botulinum neurotoxin injections in piriformis syndrome</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yi, Kyu‐Ho ; Lee, Kyu‐Lim ; Lee, Ji‐Hyun ; Hu, Hye‐Won ; Lee, Kangwoo ; Seo, Kyle K. ; Kim, Hee‐Jin</creator><creatorcontrib>Yi, Kyu‐Ho ; Lee, Kyu‐Lim ; Lee, Ji‐Hyun ; Hu, Hye‐Won ; Lee, Kangwoo ; Seo, Kyle K. ; Kim, Hee‐Jin</creatorcontrib><description>Background
The piriformis muscle is normally involved in piriformis syndrome and can be treated with botulinum neurotoxin using several different injection methods. However, definitive injection guidelines for the muscle have not been reported previously.
Aims
This study aimed to determine the ideal area for injections based on the intramuscular nerve distribution as obtained using a modified Sihler's staining technique.
Materials and Methods
A modified Sihler's method was applied to the piriformis muscle in 15 specimens. The intramuscular arborization areas were identified based on two anatomical landmarks: (a) the lateral border of the sacrum bone and (b) the greater trochanter.
Results
The nerve entry point for both piriformis muscles was found in the area between the lateral border of the sacrum and one‐fifth of the distance toward the greater trochanter. The intramuscular nerve distribution for the piriformis muscle had the largest arborization patterns between one‐fifth and two‐fifths of the distance from the sacrum to the greater trochanter. The piriformis muscle was tendinous from two‐fifths of the distance to the greater trochanter.
Discussion
This study has yielded suggested optimal injection locations for the piriformis muscle relative to external anatomical landmarks.
Conclusion
Clinicians can use these guidelines to ensure the effectiveness of not only botulinum neurotoxin injections but also other agents such as steroids, anesthetics, and normal saline. These guidelines will also help to avoid adverse outcomes of injection treatments.</description><identifier>ISSN: 0897-3806</identifier><identifier>EISSN: 1098-2353</identifier><identifier>DOI: 10.1002/ca.23711</identifier><identifier>PMID: 33347678</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Anesthetics ; botulinum neurotoxin ; Botulinum toxin ; clinical guideline ; Guidelines ; Injection ; Muscles ; Neurotoxicity ; piriformis muscle ; piriformis syndrome ; Sacrum ; Steroid hormones ; Toxins ; Trochanter</subject><ispartof>Clinical anatomy (New York, N.Y.), 2021-10, Vol.34 (7), p.1028-1034</ispartof><rights>2020 American Association of Clinical Anatomists</rights><rights>2020 American Association of Clinical Anatomists.</rights><rights>2021 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3491-bdaf49387d220913f1ba549de52514efb7a9fbadebf8fadb40e2f1d24f502f753</citedby><cites>FETCH-LOGICAL-c3491-bdaf49387d220913f1ba549de52514efb7a9fbadebf8fadb40e2f1d24f502f753</cites><orcidid>0000-0002-1139-6261</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fca.23711$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fca.23711$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33347678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yi, Kyu‐Ho</creatorcontrib><creatorcontrib>Lee, Kyu‐Lim</creatorcontrib><creatorcontrib>Lee, Ji‐Hyun</creatorcontrib><creatorcontrib>Hu, Hye‐Won</creatorcontrib><creatorcontrib>Lee, Kangwoo</creatorcontrib><creatorcontrib>Seo, Kyle K.</creatorcontrib><creatorcontrib>Kim, Hee‐Jin</creatorcontrib><title>Guidelines for botulinum neurotoxin injections in piriformis syndrome</title><title>Clinical anatomy (New York, N.Y.)</title><addtitle>Clin Anat</addtitle><description>Background
The piriformis muscle is normally involved in piriformis syndrome and can be treated with botulinum neurotoxin using several different injection methods. However, definitive injection guidelines for the muscle have not been reported previously.
Aims
This study aimed to determine the ideal area for injections based on the intramuscular nerve distribution as obtained using a modified Sihler's staining technique.
Materials and Methods
A modified Sihler's method was applied to the piriformis muscle in 15 specimens. The intramuscular arborization areas were identified based on two anatomical landmarks: (a) the lateral border of the sacrum bone and (b) the greater trochanter.
Results
The nerve entry point for both piriformis muscles was found in the area between the lateral border of the sacrum and one‐fifth of the distance toward the greater trochanter. The intramuscular nerve distribution for the piriformis muscle had the largest arborization patterns between one‐fifth and two‐fifths of the distance from the sacrum to the greater trochanter. The piriformis muscle was tendinous from two‐fifths of the distance to the greater trochanter.
Discussion
This study has yielded suggested optimal injection locations for the piriformis muscle relative to external anatomical landmarks.
Conclusion
Clinicians can use these guidelines to ensure the effectiveness of not only botulinum neurotoxin injections but also other agents such as steroids, anesthetics, and normal saline. These guidelines will also help to avoid adverse outcomes of injection treatments.</description><subject>Anesthetics</subject><subject>botulinum neurotoxin</subject><subject>Botulinum toxin</subject><subject>clinical guideline</subject><subject>Guidelines</subject><subject>Injection</subject><subject>Muscles</subject><subject>Neurotoxicity</subject><subject>piriformis muscle</subject><subject>piriformis syndrome</subject><subject>Sacrum</subject><subject>Steroid hormones</subject><subject>Toxins</subject><subject>Trochanter</subject><issn>0897-3806</issn><issn>1098-2353</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQQIMotlbBXyALXrxszedmcyylVqHgRc8h2SSQ0t3UZBftvzd1qzdPMwOPN_AAuEVwjiDEj42aY8IROgNTBEVdYsLIOZjCWvCS1LCagKuUthAiRHl9CSaEEMorXk_Baj14Y3e-s6lwIRY69EO-hrbo7BBDH758V_hua5vehy7ltdj76DPa-lSkQ2diaO01uHBql-zNac7A-9Pqbflcbl7XL8vFpmwIFajURjkqSM0NxlAg4pBWjApjGWaIWqe5Ek4rY7WrnTKaQosdMpg6BrHjjMzA_ejdx_Ax2NTLbRhil19KzDgUVY5RZephpJoYUorWyX30rYoHiaA89pKNkj-9Mnp3Eg66teYP_A2UgXIEPv3OHv4VyeViFH4DwrB0Qg</recordid><startdate>202110</startdate><enddate>202110</enddate><creator>Yi, Kyu‐Ho</creator><creator>Lee, Kyu‐Lim</creator><creator>Lee, Ji‐Hyun</creator><creator>Hu, Hye‐Won</creator><creator>Lee, Kangwoo</creator><creator>Seo, Kyle K.</creator><creator>Kim, Hee‐Jin</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TS</scope><scope>H94</scope><scope>JQ2</scope><scope>K9.</scope><orcidid>https://orcid.org/0000-0002-1139-6261</orcidid></search><sort><creationdate>202110</creationdate><title>Guidelines for botulinum neurotoxin injections in piriformis syndrome</title><author>Yi, Kyu‐Ho ; Lee, Kyu‐Lim ; Lee, Ji‐Hyun ; Hu, Hye‐Won ; Lee, Kangwoo ; Seo, Kyle K. ; Kim, Hee‐Jin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3491-bdaf49387d220913f1ba549de52514efb7a9fbadebf8fadb40e2f1d24f502f753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anesthetics</topic><topic>botulinum neurotoxin</topic><topic>Botulinum toxin</topic><topic>clinical guideline</topic><topic>Guidelines</topic><topic>Injection</topic><topic>Muscles</topic><topic>Neurotoxicity</topic><topic>piriformis muscle</topic><topic>piriformis syndrome</topic><topic>Sacrum</topic><topic>Steroid hormones</topic><topic>Toxins</topic><topic>Trochanter</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yi, Kyu‐Ho</creatorcontrib><creatorcontrib>Lee, Kyu‐Lim</creatorcontrib><creatorcontrib>Lee, Ji‐Hyun</creatorcontrib><creatorcontrib>Hu, Hye‐Won</creatorcontrib><creatorcontrib>Lee, Kangwoo</creatorcontrib><creatorcontrib>Seo, Kyle K.</creatorcontrib><creatorcontrib>Kim, Hee‐Jin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Physical Education Index</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Clinical anatomy (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yi, Kyu‐Ho</au><au>Lee, Kyu‐Lim</au><au>Lee, Ji‐Hyun</au><au>Hu, Hye‐Won</au><au>Lee, Kangwoo</au><au>Seo, Kyle K.</au><au>Kim, Hee‐Jin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Guidelines for botulinum neurotoxin injections in piriformis syndrome</atitle><jtitle>Clinical anatomy (New York, N.Y.)</jtitle><addtitle>Clin Anat</addtitle><date>2021-10</date><risdate>2021</risdate><volume>34</volume><issue>7</issue><spage>1028</spage><epage>1034</epage><pages>1028-1034</pages><issn>0897-3806</issn><eissn>1098-2353</eissn><abstract>Background
The piriformis muscle is normally involved in piriformis syndrome and can be treated with botulinum neurotoxin using several different injection methods. However, definitive injection guidelines for the muscle have not been reported previously.
Aims
This study aimed to determine the ideal area for injections based on the intramuscular nerve distribution as obtained using a modified Sihler's staining technique.
Materials and Methods
A modified Sihler's method was applied to the piriformis muscle in 15 specimens. The intramuscular arborization areas were identified based on two anatomical landmarks: (a) the lateral border of the sacrum bone and (b) the greater trochanter.
Results
The nerve entry point for both piriformis muscles was found in the area between the lateral border of the sacrum and one‐fifth of the distance toward the greater trochanter. The intramuscular nerve distribution for the piriformis muscle had the largest arborization patterns between one‐fifth and two‐fifths of the distance from the sacrum to the greater trochanter. The piriformis muscle was tendinous from two‐fifths of the distance to the greater trochanter.
Discussion
This study has yielded suggested optimal injection locations for the piriformis muscle relative to external anatomical landmarks.
Conclusion
Clinicians can use these guidelines to ensure the effectiveness of not only botulinum neurotoxin injections but also other agents such as steroids, anesthetics, and normal saline. These guidelines will also help to avoid adverse outcomes of injection treatments.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>33347678</pmid><doi>10.1002/ca.23711</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-1139-6261</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0897-3806 |
ispartof | Clinical anatomy (New York, N.Y.), 2021-10, Vol.34 (7), p.1028-1034 |
issn | 0897-3806 1098-2353 |
language | eng |
recordid | cdi_proquest_journals_2570960026 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Anesthetics botulinum neurotoxin Botulinum toxin clinical guideline Guidelines Injection Muscles Neurotoxicity piriformis muscle piriformis syndrome Sacrum Steroid hormones Toxins Trochanter |
title | Guidelines for botulinum neurotoxin injections in piriformis syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A40%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Guidelines%20for%20botulinum%20neurotoxin%20injections%20in%20piriformis%20syndrome&rft.jtitle=Clinical%20anatomy%20(New%20York,%20N.Y.)&rft.au=Yi,%20Kyu%E2%80%90Ho&rft.date=2021-10&rft.volume=34&rft.issue=7&rft.spage=1028&rft.epage=1034&rft.pages=1028-1034&rft.issn=0897-3806&rft.eissn=1098-2353&rft_id=info:doi/10.1002/ca.23711&rft_dat=%3Cproquest_cross%3E2570960026%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2570960026&rft_id=info:pmid/33347678&rfr_iscdi=true |